Global Medical REIT Inc. (NYSE:XRN) Receives Average Recommendation of “Hold” from Brokerages

Posted by Brian Himes on Jul 5th, 2026

Shares of Global Medical REIT Inc. (NYSE:XRN – Get Free Report) have received a consensus rating of “Hold” from the eight brokerages that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $40.00.

A number of brokerages have issued reports on XRN. Citizens Jmp boosted their price target on Global Medical REIT from $40.00 to $42.00 and gave the company a “market outperform” rating in a report on Tuesday, May 26th. Compass Point reaffirmed a “neutral” rating and set a $38.00 target price (down from $50.00) on shares of Global Medical REIT in a report on Thursday, May 7th. Raymond James Financial started coverage on shares of Global Medical REIT in a research note on Wednesday, June 17th. They issued a “market perform” rating for the company. Weiss Ratings cut Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, May 11th. Finally, Wall Street Zen lowered Global Medical REIT from a “hold” rating to a “sell” rating in a research note on Saturday, May 9th.

Get Our Latest Analysis on XRN

Insider Buying and Selling at Global Medical REIT

In other Global Medical REIT news, CEO Mark Okey Decker, Jr. bought 5,000 shares of the stock in a transaction dated Tuesday, May 12th. The shares were acquired at an average cost of $33.94 per share, for a total transaction of $169,700.00. Following the completion of the transaction, the chief executive officer owned 59,774 shares in the company, valued at approximately $2,028,729.56. The trade was a 9.13% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Paula Crowley acquired 1,000 shares of the stock in a transaction on Monday, May 11th. The shares were acquired at an average cost of $34.00 per share, for a total transaction of $34,000.00. Following the completion of the transaction, the director directly owned 1,000 shares in the company, valued at $34,000. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. In the last quarter, insiders bought 10,974 shares of company stock worth $373,826. 8.90% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. AQR Capital Management LLC raised its stake in shares of Global Medical REIT by 9.5% during the 1st quarter. AQR Capital Management LLC now owns 58,538 shares of the company’s stock worth $512,000 after buying an additional 5,062 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in shares of Global Medical REIT by 23,920.0% during the first quarter. Jones Financial Companies Lllp now owns 24,020 shares of the company’s stock valued at $210,000 after buying an additional 23,920 shares during the period. Goldman Sachs Group Inc. boosted its position in Global Medical REIT by 13.2% during the first quarter. Goldman Sachs Group Inc. now owns 388,605 shares of the company’s stock worth $3,400,000 after acquiring an additional 45,243 shares during the last quarter. Strs Ohio purchased a new position in Global Medical REIT during the first quarter worth about $95,000. Finally, Envestnet Asset Management Inc. raised its stake in Global Medical REIT by 39.5% during the second quarter. Envestnet Asset Management Inc. now owns 26,617 shares of the company’s stock worth $184,000 after purchasing an additional 7,536 shares during the period. 57.52% of the stock is owned by hedge funds and other institutional investors.

Global Medical REIT Price Performance

Shares of XRN opened at $37.92 on Friday. The business’s 50-day moving average is $35.84 and its two-hundred day moving average is $35.42. The company has a market capitalization of $501.88 million, a P/E ratio of -34.16 and a beta of 1.10. Global Medical REIT has a fifty-two week low of $29.05 and a fifty-two week high of $39.93. The company has a debt-to-equity ratio of 1.68, a quick ratio of 0.68 and a current ratio of 0.68.

Global Medical REIT Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Friday, September 18th. Shareholders of record on Thursday, August 20th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Thursday, August 20th. This represents a c) dividend on an annualized basis and a dividend yield of 5.1%. Global Medical REIT’s dividend payout ratio is presently -172.97%.

About Global Medical REIT

(Get Free Report)

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.